The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Giuffre Randall Michael | Director | Grant(A) | 40K | — | $0 |
| Jun 1, 2026 | Kuntz Richard | Director | Grant(A) | 40K | — | $0 |
| Jun 1, 2026 | O'Connor Daniel J. | Director | Grant(A) | 40K | — | $0 |
| Jun 1, 2026 | Lewis Tanya | Director | Grant(A) | 40K | — | $0 |
| Jun 1, 2026 | Semba Charles Pauling | Director | Grant(A) | 40K | — | $0 |
| Jun 1, 2026 | Parsons James T. | Director | Grant(A) | 51K | — | $0 |
| Jun 1, 2026 | Pauls Dietrich John | President & CEO, Director | Grant(A) | 380K | — | $0 |
| Jun 1, 2026 | Kellen Scott | CFO & Secretary | Grant(A) | 162K | — | $0 |
| Jun 1, 2026 | Krop Julie | Chief Medical Officer | Grant(A) | 68K | — | $0 |
| Jan 2, 2026 | Giuffre Randall Michael | Director | Grant(A) | 6K | $8.42 | $52K |
| Jan 2, 2026 | Parsons James T. | Director | Grant(A) | 10K | $8.42 | $85K |
| Jan 2, 2026 | Semba Charles Pauling | Director | Grant(A) | 3K | $8.42 | $28K |
| Nov 25, 2025 | Trill AB | 10% Owner | Buy(P) | 73K | $8.57 | $626K |
| Nov 24, 2025 | Trill AB | 10% Owner | Buy(P) | 40K | $7.89 | $318K |
| Nov 21, 2025 | Trill AB | 10% Owner | Buy(P) | 209K | $7.41 | $1.5M |
| Nov 21, 2025 | Parsons James T. | Director | Option exercise(M) | 12K | $2.20 | $26K |
| Nov 21, 2025 | Parsons James T. | Director | Option exercise(M) | 12K | — | $0 |
| Nov 20, 2025 | Trill AB | 10% Owner | Buy(P) | 128K | $7.41 | $952K |
| Nov 19, 2025 | Trill AB | 10% Owner | Buy(P) | 240K | $7.21 | $1.7M |
| Nov 18, 2025 | Trill AB | 10% Owner | Buy(P) | 183K | $6.75 | $1.2M |
| Nov 17, 2025 | Trill AB | 10% Owner | Buy(P) | 187K | $6.52 | $1.2M |
| Aug 27, 2025 | Stahlberg Jan | 10% Owner | Buy(P) | 51K | $6.00 | $305K |
| Aug 26, 2025 | Stahlberg Jan | 10% Owner | Buy(P) | 60K | $6.00 | $358K |
| Aug 25, 2025 | Stahlberg Jan | 10% Owner | Buy(P) | 338K | $6.00 | $2.0M |
| Aug 22, 2025 | Stahlberg Jan | 10% Owner | Buy(P) | 60K | $5.96 | $356K |
| Aug 21, 2025 | Stahlberg Jan | 10% Owner | Buy(P) | 48K | $5.96 | $287K |
| Aug 20, 2025 | Stahlberg Jan | 10% Owner | Buy(P) | 71K | $5.86 | $417K |
| Aug 15, 2025 | Stahlberg Jan | 10% Owner | Buy(P) | 8K | $6.00 | $49K |
| Aug 14, 2025 | Stahlberg Jan | 10% Owner | Buy(P) | 70K | $5.99 | $422K |
| Aug 13, 2025 | Stahlberg Jan | 10% Owner | Buy(P) | 294K | $5.91 | $1.7M |
| Aug 11, 2025 | Krop Julie | Chief Marketing Officer | Grant(A) | 450K | — | $0 |
| Jul 23, 2025 | Von Koch Thomas | 10% Owner | Buy(P) | 2.9M | $3.50 | $10.0M |
| Jul 23, 2025 | Stahlberg Jan | 10% Owner | Buy(P) | 1.5M | $3.50 | $5.4M |
| Jul 23, 2025 | Jacinto Richard II | 10% Owner | Buy(P) | 400K | $3.50 | $1.4M |
| Jun 1, 2025 | Giuffre Randall Michael | Director | Grant(A) | 32K | — | $0 |
| Jun 1, 2025 | Kellen Scott | CFO & Secretary | Grant(A) | 225K | — | $0 |
| Jun 1, 2025 | Kuntz Richard | Director | Grant(A) | 32K | — | $0 |
| Jun 1, 2025 | Lewis Tanya | Director | Grant(A) | 32K | — | $0 |
| Jun 1, 2025 | Parsons James T. | Director | Grant(A) | 41K | — | $0 |
| Jun 1, 2025 | Pauls Dietrich John | President & CEO, Director | Grant(A) | 600K | — | $0 |
| Jun 1, 2025 | Semba Charles Pauling | Director | Grant(A) | 32K | — | $0 |
| Jun 1, 2025 | Wambeke David J. | Chief Business Officer | Grant(A) | 250K | — | $0 |
| Apr 7, 2025 | Pilnik Richard D. | Director | Option exercise(M) | 24K | $2.11 | $51K |
| Apr 7, 2025 | Pilnik Richard D. | Director | Option exercise(M) | 24K | — | $0 |
| Feb 20, 2025 | O'Connor Daniel J. | Director | Grant(A) | 64K | — | $0 |
| Feb 13, 2025 | Giuffre Randall Michael | Director | Option exercise(M) | 12K | $2.11 | $25K |
| Feb 13, 2025 | Giuffre Randall Michael | Director | Option exercise(M) | 5K | $3.65 | $18K |
| Feb 13, 2025 | Giuffre Randall Michael | Director | Option exercise(M) | 12K | — | $0 |
| Feb 13, 2025 | Giuffre Randall Michael | Director | Option exercise(M) | 5K | — | $0 |
| Jan 2, 2025 | Semba Charles Pauling | Director | Grant(A) | 5K | $5.34 | $28K |
| Jan 2, 2025 | Pilnik Richard D. | Director | Grant(A) | 10K | $5.34 | $55K |
| Jan 2, 2025 | Kuntz Richard | Director | Grant(A) | 10K | $5.34 | $53K |
| Jan 2, 2025 | Giuffre Randall Michael | Director | Grant(A) | 11K | $5.34 | $58K |
| Jan 2, 2025 | Parsons James T. | Director | Grant(A) | 16K | $5.34 | $85K |
| Jan 2, 2025 | Parsons James T. | Director | Grant(A) | 4K | — | $0 |
| Jun 28, 2024 | Stahlberg Jan | 10% Owner | Buy(P) | 1.2M | $2.50 | $3.0M |
| Jun 28, 2024 | TomEnterprise Private AB | 10% Owner | Buy(P) | 1.2M | $2.50 | $3.0M |
| Jun 1, 2024 | Giuffre Randall Michael | Director | Grant(A) | 28K | — | $0 |
| Jun 1, 2024 | Kuntz Richard | Director | Grant(A) | 28K | — | $0 |
| Jun 1, 2024 | Lewis Tanya | Director | Grant(A) | 28K | — | $0 |
| Jun 1, 2024 | Parsons James T. | Director | Grant(A) | 28K | — | $0 |
| Jun 1, 2024 | Pilnik Richard D. | Director | Grant(A) | 36K | — | $0 |
| Jun 1, 2024 | Semba Charles Pauling | Director | Grant(A) | 28K | — | $0 |
| Jun 1, 2024 | Pauls Dietrich John | President and CEO, Director | Grant(A) | 300K | — | $0 |
| Jun 1, 2024 | Cundari Dominic R | Chief Commercial Officer | Grant(A) | 15K | — | $0 |
| Jun 1, 2024 | Kellen Scott | CFO and Secretary | Grant(A) | 130K | — | $0 |
| Jun 1, 2024 | Wambeke David J. | Chief Business Officer | Grant(A) | 130K | — | $0 |
| Jan 22, 2024 | Lorianne Masuoka K. | Chief Medical Officer | Grant(A) | 285K | — | $0 |
| Jan 2, 2024 | Giuffre Randall Michael | Director | Grant(A) | 19K | $2.80 | $54K |
| Jan 2, 2024 | Parsons James T. | Director | Grant(A) | 21K | $2.80 | $60K |
| Jan 2, 2024 | Pilnik Richard D. | Director | Grant(A) | 30K | $2.80 | $85K |
| Jan 2, 2024 | Kuntz Richard | Director | Grant(A) | 14K | $2.80 | $40K |
| Jan 2, 2024 | Semba Charles Pauling | Director | Grant(A) | 9K | $2.80 | $26K |
| Nov 16, 2023 | Wambeke David J. | Chief Business Officer | Buy(P) | 20K | $2.46 | $49K |
| Jun 23, 2023 | TomEqt Private AB | 10% Owner | Buy(P) | 1.5M | $3.40 | $5.0M |
| Jun 23, 2023 | Pilnik Richard D. | Director | Buy(P) | 38K | $3.91 | $150K |
| Jun 23, 2023 | Wambeke David J. | Chief Business Officer | Buy(P) | 38K | $3.91 | $150K |
| Jun 23, 2023 | Kellen Scott | CFO and Secretary | Buy(P) | 10K | $3.91 | $39K |
| Jun 23, 2023 | Semba Charles Pauling | Director | Buy(P) | 13K | $3.91 | $50K |
| Jun 23, 2023 | Pauls Dietrich John | President and CEO, Director | Buy(P) | 13K | $3.91 | $50K |
| Jun 23, 2023 | Giuffre Randall Michael | Director | Gift(G) | 15K | — | $0 |
| Jun 23, 2023 | Giuffre Randall Michael | Director | Buy(P) | 65K | $3.91 | $254K |
| Jun 1, 2023 | Giuffre Randall Michael | Director | Grant(A) | 17K | — | $0 |
| Jun 1, 2023 | Lewis Tanya | Director | Grant(A) | 7K | — | $0 |
| Jun 1, 2023 | Parsons James T. | Director | Grant(A) | 17K | — | $0 |
| Jun 1, 2023 | Pilnik Richard D. | Director | Grant(A) | 22K | — | $0 |
| Jun 1, 2023 | Semba Charles Pauling | Director | Grant(A) | 17K | — | $0 |
| Jun 1, 2023 | Pauls Dietrich John | President and CEO, Director | Grant(A) | 181K | — | $0 |
| Jun 1, 2023 | Kellen Scott | CFO and Secretary | Grant(A) | 67K | — | $0 |
| Jun 1, 2023 | Gruis Kirsten L | Chief Medical Officer | Grant(A) | 67K | — | $0 |
| Jun 1, 2023 | Cundari Dominic R | Chief Commercial Officer | Grant(A) | 27K | — | $0 |
| Jun 1, 2023 | Daves Julie VanOrsdel | SVP Clinical Development Oper. | Grant(A) | 54K | — | $0 |
| May 30, 2023 | Kuntz Richard | Director | Grant(A) | 32K | — | $0 |
| Apr 10, 2023 | Wambeke David J. | Chief Business Officer | Buy(P) | 469K | $1.60 | $750K |
| Apr 10, 2023 | Wambeke David J. | Chief Business Officer | Grant(A) | 140K | — | $0 |
| Mar 1, 2023 | Lewis Tanya | Director | Grant(A) | 26K | — | $0 |
| Jan 3, 2023 | Pilnik Richard D. | Director | Grant(A) | 56K | $1.53 | $85K |
| Jan 3, 2023 | Semba Charles Pauling | Director | Grant(A) | 17K | $1.53 | $26K |
| Jan 3, 2023 | Burroughs Amy L. | Director | Grant(A) | 17K | $1.53 | $26K |
| Jan 3, 2023 | Giuffre Randall Michael | Director | Grant(A) | 35K | $1.53 | $54K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-21. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).